Cell Penetrating Peptide Global Market is Projected to Increase Revenues Growth, Business Insights, Future Demand and Forecast 2024-2033
Overview and Scope
Cell-penetrating peptides (CPPs), also known as protein transduction domains
(PTDs) or membrane translocation peptides, are short peptides typically
composed of 5 to 30 amino acids with the ability to traverse cell membranes and
facilitate the intracellular delivery of various cargo molecules, including
proteins, nucleic acids, and small molecules. It transports diverse cargoes
across biological barriers, including the plasma membrane, endosomal membranes,
and nuclear envelope, without causing significant cellular damage.
Sizing and Forecast
The cell penetration peptide market size has grown rapidly in recent years. It
will grow from $1.63 billion in 2023 to $1.87 billion in 2024 at a compound
annual growth rate (CAGR) of 14.9%. The
growth in the historic period can be attributed to increased understanding of
cellular uptake mechanisms, growth in demand for targeted drug delivery
systems, rising prevalence of chronic diseases, emergence of personalized
medicine approaches, and expansion of pharmaceutical research and development.
The cell penetration peptide market size is expected to see rapid growth in the
next few years. It will grow to $3.31 billion in 2028 at a compound annual
growth rate (CAGR) of 15.3%. The growth
in the forecast period can be attributed to development of novel peptide-based
therapeutics for rare diseases, growing investment in healthcare infrastructure
in emerging markets, rising demand for peptide-based vaccines and
immunotherapies, regulatory initiatives to streamline approval processes for
peptide drugs, and shift towards sustainable and biodegradable peptide delivery
systems. Major trends in the forecast period include customization of cell
penetration peptides for specific therapeutic applications, exploration of
cell-penetrating peptides as tools for intracellular delivery, integration of
artificial intelligence and machine learning in peptide design, integration of
cell-penetrating peptides, and adoption of novel delivery routes.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-penetrating-peptide-global-market-report
Segmentation & Regional Insights
The cell penetrating peptide market covered in this report is segmented –
1) By Type: Synthetic Cell Penetrating Peptides, Protein-Derived Cell
Penetrating Peptides, Chimeric Cell Penetrating Peptides
2) By Application: Drug Delivery, Gene Delivery, Diagnostics, Molecular
Imaging, Other Applications
3) By End Use: Pharmaceutical And Biotechnology Companies, Contract Research
Organization (CROs), Hospitals And Clinics, Others End Users
North America was the largest region in the cell penetrating peptide market in
2023. Asia-Pacific is expected to be the fastest-growing region in the forecast
period. The regions covered in the cell penetrating peptide market report are
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the
report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15537&type=smp
Major Driver Impacting Market Growth
The increasing investment in health research and development is expected to
propel the growth of the cell penetration peptide market going forward. Health
research and development (R&D) refers to the systematic investigation and
experimentation to advance scientific knowledge and develop innovative
solutions to improve healthcare outcomes. Health research and development
increase is due to healthcare needs, technological progress, global health
priorities, investment incentives, and economic opportunities. Cell penetration
peptides offer versatile and efficient strategies for delivering biomolecules
and therapeutics into cells by advancing various health research and
development aspects, including drug delivery, gene therapy, vaccine
development, molecular imaging, and cellular research. For instance, in
December 2023, according to the National Center for Science and Engineering
Statistics, a US-based federal statistical agency, state government agencies
allocated $1.10 billion towards health research and experimental development
(R&D) in the fiscal year 2022, marking a 2.2% rise compared to the $1.07
billion spent in fiscal year 2021. Therefore, the surge in research and
development is driving the growth of the cell penetration peptide market.
Key Industry Players
Major companies operating in the cell penetrating peptide market are Thermo Fisher Scientific Inc., Novo Nordisk
A/S, Merck KGaA, Corden Pharma GmbH, Sarepta Therapeutics Inc., GenScript
Biotech Corporation, Bachem Holding AG, R&D Systems Inc., PolyPeptide
Laboratories AB, PeptiDream Inc., Revance Therapeutics Inc., CPC Scientific
Inc., Tocris Bioscience, Bio-Synthesis Inc., AnaSpec Inc., Avidity Biosciences
Inc., Iris Biotech GmbH, PEPperPRINT GmbH, Chemos GmbH & Co. KG, Creative
Peptides GmbH, ProImmune Ltd., Pepscan Inc., The Cupid Peptide Company,
AltaBioscience Ltd., Peptomyc
The cell penetrating peptide market report table of contents includes:
1. Executive Summary
2. Cell Penetrating Peptide Market Characteristics
3. Cell Penetrating Peptide Market Trends And Strategies
4. Cell Penetrating Peptide Market - Macro Economic Scenario
5. Global Cell Penetrating Peptide Market Size and Growth
.....
32. Global Cell Penetrating Peptide Market Competitive
Benchmarking
33. Global Cell Penetrating Peptide Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cell Penetrating Peptide
Market
35. Cell Penetrating Peptide Market Future Outlook and Potential
Analysis
36. Appendix
Explore the trending research reports from TBRC:
https://topprnews.com/gluten-feed-market
https://topprnews.com/organic-feed-market
https://topprnews.com/organic-pigments-market
https://goodprnews.com/rapeseed-oil-market
https://goodprnews.com/gluten-feed-market
https://goodprnews.com/manufactured-soil-market
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info
Healthcare Blog: https://healthcareresearchreports.com
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment